ArticleJAMIA open2026
Patient-reported outcomes in radiotherapy (PRO-RT) utilizing an integrated patient portal; results from a prospective single-arm trial.
Article in JAMIA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This prospective single-arm trial assessed the use of an integrated patient platform (IPP) and effects on patient-reported outcomes survey (PROs) completion. Materials and Methods: Head and neck, breast, and thoracic cancer patients undergoing radiotherapy (RT) were approached for registration for an IPP for PRO administration and integration of multiple health portals. Results: Seventy-two patients were approached, 27 (38%) enrolled, and 18 used the IPP for PROs, 2 of which utilized integrative features. IPP user PRO completion rates were 100%, 89%, 89%, and 94% at baseline, end of RT, and 3- and 6-months post-RT, higher than the standard interface. Of the 45 who declined, 24 (53%) reported information security concerns. Discussion: While the IPP increased PRO completion, many declined enrollment, citing security concerns. Few utilized the portal's integrative features. Conclusion: IPPs show promise in aiding PRO completion; continued efforts to demonstrate data safety and utility of IPPs are merited.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.